Want to see SE:ORGC full AI Analyst Report?
ORGC Stock Chart & Stats
kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.30 - kr2.07
Previous CloseN/A
Volume11.05K
Average Volume (3M)87.89K
Market Cap
kr75.30M
Enterprise Valuekr130.45
Total Cash (Recent Filing)kr3.05M
Total Debt (Recent Filing)kr77.43M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding183,219,120
10 Day Avg. Volume18,569
30 Day Avg. Volume87,893
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)kr113.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Bio-based ChemistryOrganoClick’s proprietary bio-based chemistry represents a durable competitive advantage in an industry shifting toward sustainability. Ownership of specialized formulations supports differentiation, protects margin potential when adopted, and enables expansion into multiple industrial applications over the medium term.
Improving Operating Cash FlowA shift to positive operating cash flow signals improving underlying operating discipline and working-capital management. Sustained OCF provides a foundation to reduce external funding needs, fund essential R&D or scaling, and buy time to address profitability across the medium term.
Industrial Customer Recurring DemandRevenue derived from industrial customers integrating the chemistry implies recurring, contract-like demand. Such customer stickiness supports predictable revenue streams, enables scale efficiencies in production, and improves the odds of durable gross-income generation as adoption grows.
Bears Say
Very High Financial LeverageExtremely high leverage materially increases refinancing, interest-rate, and solvency risk. With a thin equity cushion, operational setbacks or slower adoption could force dilutive financing or restructuring, constraining long-term strategic flexibility and investments.
Negative Free Cash FlowPersistent negative free cash flow means the business still requires external capital to fund investments or service debt despite positive operating cash flow. Continued cash burn limits the company’s ability to self-fund growth, repay leverage, or withstand cyclical headwinds.
Declining Revenue And Weak MarginsA declining top line combined with low gross margins and deep net losses impairs operating leverage and the pathway to sustainable profitability. Structural margin weakness reduces internal capital generation, prolongs reliance on external financing, and weakens competitive positioning over months.
OrganoClick AB News
ORGC FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr0.30 and its highest was kr2.07 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is kr75.30M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Nov 05, 2026 which is in 83 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on Aug 12, 2026. The company reported -kr0.037 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -kr0.037 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.474%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in SE:ORGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―